CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Telefonaktiebolaget LM Ericsson Investors of a Lead Plaintiff Deadline of May 2, 2022

NEW YORK, April 4, 2022 /PRNewswire/ — Attention Telefonaktiebolaget LM Ericsson (“Telefonaktiebolaget LM Ericsson”) (NASDAQ: ERIC) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between April 27, 2017…

Pharming anuncia datos positivos del ensayo de fase II/III de leniolisib presentado en la Reunión Anual de la Sociedad de Inmunología Clínica 2022

LEIDEN, Países Bajos, 3 de abril de 2022 /PRNewswire/ — Pharming Group N.V. (“Pharming” o “la Compañía”) (EURONEXT Ámsterdam: PHARM/Nasdaq: PHAR) anuncia nuevos datos del ensayo pivotal de fase II/III de leniolisib para el tratamiento del síndrome de fosfoinositido 3-quinasa delta…

Pharming anuncia dados positivos do estudo clínico de Leniolisibe de fase II/III apresentados na Reunião Anual da Sociedade de Imunologia Clínica de 2022

LEIDA, Países Baixos, 3 de abril de 2022 /PRNewswire/ — Pharming Group N.V. (“Pharming” ou “a Empresa”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) anuncia novos dados do estudo clínico pivotal do Leniolisibe de fase II/III para o tratamento de síndrome de fosfoinositídeo 3-quinase delta…

Jahrestagung 2022 der Clinical Immunology Society: Pharming gibt positive Daten aus Leniolisib-Studie der Phase II/III bekannt

LEIDEN, Niederlande, 3. April 2022 /PRNewswire/ — Pharming Group N.V. („Pharming” oder „das Unternehmen”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) gibt neue Daten aus der zulassungsrelevanten Phase-II/III-Studie mit Leniolisib zur Behandlung des aktivierten PI3K-Delta-(PI3Kδ)-Syndroms…

Présentation des données positives de l’essai de phase II/III sur le leniolisib par Pharming lors de la réunion annuelle 2022 de la Clinical Immunology Society.

LEIDEN, Pays-Bas, 3 avril 2022 /PRNewswire/ — Pharming Group N.V. (« Pharming » ou « la Société ») (EURONEXT Amsterdam : PHARM/Nasdaq: PHAR) annonce de nouvelles données issues de l’essai pivot de phase II/III du leniolisib pour le traitement du syndrome de la phosphoinositide 3-kinase…

Metaverse game ecosystem, DeHorizon to launch MMO/RPG DeVerse on Polygon Mainnet

SAN FRANCISCO, April 3, 2022 /PRNewswire/ — DeHorizon, the next-gen metaverse game ecosystem, today announced that their first game DeVerse is to launch on Polygon Mainnet, the leading platform for Ethereum scaling and infrastructure development. Polygon-based DeVerse may enable the…

Kennan Salinero, Co-Founder and Executive Director of ReImagine Science, Speaks to the NextNow Community

WASHINGTON, April 1, 2022 /PRNewswire/ — On Sunday April 3, 8PM EDT, Kennan Salinero will be speaking to the NextNow community about “Collective Practices for Transforming What it is to Be a Scientist” What keeps core issues to biomedical science in place? What is the cost to society,…

M&T Bank Corporation Completes Acquisition of People’s United Financial, Inc.

Combined company creates a $200 billion banking franchise serving communities in the Northeast and Mid-Atlantic from Maine to Virginia and Washington, D.C. Systems conversion expected to take place in the third quarter of 2022 BUFFALO, N.Y., April 2, 2022 /PRNewswire/ — M&T Bank…

Youth Impact Center to Celebrate Grand Opening in Fort Lauderdale Saturday, April 2

No-Cost, After School Center Offers Academic, Athletic, Social, and Personal Space for Youth Ages 6-18 FORT LAUDERDALE, Fla., April 2, 2022 /PRNewswire/ — Fort Lauderdale Mayor Dean Trantalis will join South Florida’s Chen Family Mission Foundation for the opening of the foundation’s…

Huobi Global Launches Grid Trading Bot on Its Mobile APP, Spurs Traders to Profit From Price Volatility

LONDON, April 2, 2022 /PRNewswire/ — Huobi Global, one of the world’s leading global exchanges, has unveiled a trading bot on its Huobi Global mobile app that will enable investors to capitalize on price volatility in the cryptocurrency market. The trading bot allows users to place, buy,…

« Previous Page — Next Page »